Blockbusters and controlled substances: Miltown, Quaalude, and consumer demand for drugs in postwar America

Studies in History and Philosophy of Science Part C :Studies in History and Philosophy of Biological and Biomedical Sciences

Volumn 42, Issue 4, 2011, Pages 415-426

  Herzberg, David ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Drug advertising; Drug control; Medical consumerism; Miltown (meprobamate); Pharmaceutical history; Quaalde (methaqualone)

Indexed keywords

HYPNOTIC SEDATIVE AGENT; MEPROBAMATE; METHAQUALONE; PRESCRIPTION DRUG;

ARTICLE; DRUG INDUSTRY; DRUG LEGISLATION; ETHICS; HEALTH SERVICE; HISTORY; HUMAN; LEGAL ASPECT; MARKETING; MENTAL STRESS; OUTPATIENT DEPARTMENT; UNITED STATES;

AMBULATORY CARE FACILITIES; DRUG INDUSTRY; HEALTH SERVICES NEEDS AND DEMAND; HISTORY, 20TH CENTURY; HUMANS; HYPNOTICS AND SEDATIVES; LEGISLATION, DRUG; MARKETING; MEPROBAMATE; METHAQUALONE; PRESCRIPTION DRUGS; STRESS, PSYCHOLOGICAL; UNITED STATES;

EID: 82555189810     PISSN: 13698486     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.shpsc.2011.05.005     Document Type: Article

References (118)

1. Ager S. Luding out. New England Journal of Medicine 1972, 281(1):51.
2. Angell M. The truth about the drug companies: How they deceive us and what to do about it 2005, Random House, New York.
3. Axton, J. (n.d.). Survival information-A report on Qs and Other meth drugs. Do It Now Foundation, 3(1).
4. Ayd, F. (1958). Testimony. False and Misleading Advertising (Prescription Tranquilizing Drugs). Hearings before the subcommittee on legal and marketing affairs of the committee on government operations, United States House of Representatives, February 11, 12, 24, 26. Washington: Government Printing Office.
5. Barbanel, J. (1982). 2 Physicians get terms on " Drug Resort" charge. New York Times, August 27.
6. Baumohl, J. (2004). Maintaining orthodoxy: The Depression-era struggle over morphine maintenance in California. In S. Tracy, & C.J. Acker (Eds.), Altering American consciousness: Essays on the history of alcohol and drug use in the United States, 1800-2000 (pp. 225-266). Boston: University of Massachusetts Press.
7. Blumenthal L., Fuchs M. Meprobamate: An adjunct to successful management of chronic headache. American Practitioner and Digest of Treatment 1958, 1123.
8. Bowes R. The industry as pusher. Journal of Drug Issues 1974, July, 238.
9. Bradley T. Sales promotion. Pharmaceutical marketing orientation seminar 1959, 126-133. Pharmaceutical Advertising Club of New York, New York. R.G. Kedersha (Ed.).
10. Bud R. Antibiotics, big business, and consumers: The context of government investigations into the postwar American drug industry. Technology and Culture 2005, 46(2):329-349.
11. Bud R. Penicillin: Triumph and tragedy 2007, Oxford University Press, Oxford.
12. Tranquil Pills Stir Up Doctors 1958, Business Week, June 28, 28-30.
13. Cameron, J. (1973). Pretty poison: A cold look at a hot drug. Potomac (Washington Post), February 11.
14. Cohen L. A consumers' republic 2003, Knopf, New York.
15. Cooley D. The new nerve pills and your health. Cosmopolitan 1956, January, 68-75.
16. Cooper J., Czechowicz D., Molinari S., Peterson R. Impact of prescription drug diversion control systems on medical practice and patient care: NIDA research monograph 131 1993, National Institute on Drug Abuse, Rockville.
17. Courtwright D. The controlled substances act: How a " big tent" reform became a punitive drug law. Drug and Alcohol Dependence 2004, 76:9-15.
18. Crosby, D. L., Burke, L. B., & Kennedy, J. S. (1978). Drug scheduling-What effects? In Proceedings of the annual meeting of the American pharmaceutical association.
19. Daemmrich A. Pharmacopolitics: Drug regulation in the United States and Germany 2004, University of North Carolina Press, Chapel Hill.
20. DeGrandpre R. The cult of pharmacology: How America became the world's most troubled drug culture 2006, Duke University Press, Raleigh.
21. DeTarnowsky P. Marketing. Pharmaceutical marketing orientation seminar 1959, 83-93. Pharmaceutical Advertising Club of New York, New York. R.G. Kedersha (Ed.).
22. Dowling H. Twixt the cup and the lip. The Journal of the American Medical Association 1957, 165:657-661.
23. Drake, D. (1973). " Pure Downer" Tells life of drug use, abuse. Citizen Journal, May 23.
24. Drug Awareness Warning Network. (1977-1981). Quarterly and annual reports. IMS America.
25. Dyck E. Psychedelic psychiatry: LSD from clinic to campus 2008, Johns Hopkins University Press, Baltimore.
26. Eisenberg B. Role of tranquilizing drugs in allergy. The Journal of the American Medical Association 1957, 16:936-937.
27. Falco M. Methaqualone: A study of drug control 1975, Drug Abuse Council Inc, Washington.
28. Federal Register. (1972). Vol. 37, May 11, 9500.
29. Federal Register. (1973a). Vol 38, April 11, 9170.
30. Federal Register. (1973b). Vol 38, June 12, 15470.
31. Federal Register. (1973c). Vol 37, October 4, 27517-27519.
32. Federal Register. (1973-1980). Reports on federal methaqualone manufacturing limits: Vol. 39, March 12; Vol. 39, August 1; Vol. 39, December 13, 22851; Vol. 40, August 26, 37240; Vol. 42, May 6, 23212; Vol. 42, October 19, 55853; Vol. 43, May 12, 20565; Vol. 44, April 5, 72809; Vol. 44, July 6, 39627; Vol. 46, April 29, 24045-24046.
33. Foster, M. (1963). In Smith, J., Foster, M., & Rudy, L. Tranquilizers and energizers-or neither?" Postgraduate Medicine, April 1963, 349.
34. Galton L. A new drug brings relief for the tense and anxious. Cosmopolitan 1955, August, 82-83.
35. Garland J. The play of the market place. NEJM 1956, 255:528-529.
36. Geels F., Pieters T., Snelders S. Cultural enthusiasm, resistance and the societal embedding of new technologies: Psychotropic drugs in the 20th century. Technology Analysis & Strategic Management 2007, 19(2):145-165.
37. Gootenberg P. Andean cocaine: The making of a global drug 2009, University of North Carolina Press, Chapel Hill.
38. Granik, T. (1960). American forum of the air. The Westinghouse Broadcasting Company, February 1 [in Senate Anti-Trust and Monopoly, Drugs, Accession 71A 5170, Box 19, Record Group 46, National Archives Building, Washington, DC.].
39. Greene J., Herzberg D. Hidden in plain sight: The popular promotion of prescription drugs in the 20th century. American Journal of Public Health 2010, May, 793-803.
40. Greene J., Podolsky S. Keeping modern in medicine: Pharmaceutical promotion and physician education in postwar America. Bulletin of the History of Medicine 2009, 83(2):331-377.
41. Healy D. The antidepressant era 1997, Harvard University Press, Cambridge.
42. Healy D. The creation of psychopharmacology 2002, Harvard University Press, Cambridge.
43. Herzberg D. Happy pills in America: From Miltown to Prozac 2009, Johns Hopkins University Press, Baltimore.
44. Herzberg D. " Will wonder drugs never cease!": Direct-to-consumer marketing in the golden age of American medicine. Pharmacy in History 2009, 51(2):47-56.
45. Hilts P. Protecting America's health: The FDA, business, and one hundred years of regulation 2003, Knopf, New York.
46. Hoffman E., Slade M. Centers Hooked on Methaqualone. New York Times 1981, November 29.
47. Hull R. Marketing concepts. The workings and philosophies of the pharmaceutical industry 1959, 52-63. National Pharmaceutical Council, Princeton. National Pharmaceutical Council, Inc. (Ed.).
48. Inaba D., Gay G., Newmeyer J., Whitehead C. Methaqualone abuse: " Luding out" JAMA 1973, 224(11):1505-1509.
49. Inciardi J., Petersen D.M., Chambers C.D. Methaqualone abuse patterns, diversion paths and adverse reactions. The Journal of the Florida Medical Association 1974, 61(4):279-283.
50. Jackson C.O. Food and drug legislation in the new deal 1970, Princeton University Press, Princeton.
51. Jackson C. Before the drug culture: Barbiturate/amphetamine abuse in American Society. Clio Medica 1976, 11(1):47-58.
52. Jenkins W.E. Public relations. Pharmaceutical marketing orientation seminar 1959, 145-152. Pharmaceutical Advertising Club of New York, New York. R.G. Kedersha (Ed.).
53. Kline, N. (1958). Testimony. False and Misleading Advertising (Prescription Tranquilizing Drugs). Hearings before the Subcommittee on Legal and Marketing Affairs of the Committee on Government Operations, United States House of Representatives, February 11, 12, 24, 26. Washington: Government Printing Office.
54. Lemere F. New tranquilizing drugs. Northwest Medicine 1955, October 1098-110.
55. Lewis J., Steindler E.M. Methaqualone. JAMA 1973, 224(11):1521-1522.
56. Liebenau J. Medical science and medical industry: The formation of the American Pharmaceutical Industry 1987, Johns Hopkins University Press, Baltimore.
57. Life. (1960). New Way to Calm a Cat, April 18, 93-5.
58. Lubasch A. Trial opens for seven accused in sale of Quaalude at " clinics" New York Times 1982, September 26.
59. Lubasch A. 6 Convicted of participation in Quaalude clinic scheme. New York Times 1983, March 4.
60. Maas J. Nolle Nocere, Anxiety and Medicaments. GP 1959, April, 86.
61. Marks H. Revisiting " the origins of compulsory drug prescriptions" American Journal of Public Health 1995, 85:109-115.
62. Marks H. Trust and mistrust in the marketplace: Statistics and clinical research, 1945-1960. History of Science 2000, 38:343-355.
63. Martin M. Pressures on practitioners to prescribe tranquillizers. Canadian Medical Association Journal 1960, January 16, 134.
64. McFadyen, R. (1979). The FDA's regulation and control of antibiotics in the 1950s: The Henry Welch Scandal, Félix Martí-Ibánez.
65. Metzl J. Prozac on the couch: Prescribing gender in the era of wonder drugs 2003, Duke University Press, Durham, NC.
66. Musto D. The American disease: The origins of narcotics control 1999, Oxford University Press, New York. 3rd ed.
67. Musto D., Korsmeyer P. The quest for drug control: Politics and federal policy in a period of increasing substance abuse, 1963-1981 2002, Yale University Press, New Haven.
68. National Institute on Drug Abuse. (1973 E#1, 1977 E#7, 1978 E#12, 1979 E#17, 1981 E#25). Statistical Series Annual Data: Data From the Client Oriented Data Acquisitions Process. Washington: Alcohol, Drug Abuse, and Mental Health Administration of the Department of Health and Human Services.
69. New York Times. (1981). Jury in Jersey Indicts 8 for Distributing drugs from a " Stress" Center. March 14.
70. Newsweek. (1956). Pills vs. worry-How goes the frantic quest for calm in frantic lives? May 21, 68-70.
71. Newsweek. (1973). Warning on " Sopors." February 12, 65.
72. Ognibene P. There's gold in them there pills. The New Republic 1973, April 21, 13-15.
73. Oreskes M. " Stress" centers use doctors to prescribe disputed drug. New York Times 1981, November 23.
74. Orland, F. (1959) Use and Overuse of Tranquilizers. JAMA, October 10, 633-6.
75. Osinski W. Treatment of anxiety states with meprobamate. Annals of the New York Academy of Sciences 1957, May 9, 766-771.
76. Ostrenga J. Methaqualone-A Dr. Jekyll and Mr. Hyde?. Clinical Toxicology 1973, 6(4):607-609.
77. Parry, H., Balter, M, Mellinger, G., Cisin, I., & Manheimer, D. (1973). National Patterns of Psychotherapeutic Drug Use. Archives of General Psychiatry, 28, 18-74.
78. Pascarelli E. Methaqualone abuse, the quiet epidemic. JAMA 1973, 224(11):1512-1514.
79. Perry C. Unconsciousness expansion: The sopor story. Rolling Stone 1973, March 29.
80. Pieters T., Snelders S. " From king kong pills to mother's little helpers-career cycles of two families of psychotropic drugs: The barbiturates and benzodiazepines. Canadian Bulletin of Medical History 2007, 24(1):93-112.
81. Rasmussen N. The drug industry and clinical research in interwar America: Three types of physician collaborator. Bulletin of the History of Medicine 2005, 79(1):50-80.
82. Rasmussen N. On speed: The many lives of amphetamine 2008, New York University Press, New York.
83. Rasmussen, N. (forthcoming). Panic and the Prescriber: How the Politics of Amphetamine and Sedative Abuse Shaped Physician Authority over Pharmaceuticals Since 1940. In Watkins & Greene (Eds.), The Prescription in Perspective: Therapeutic Authority in Late 20th Century America. Baltimore, MD: Johns Hopkins University Press.
84. Rose T.F. The use and abuse of the tranquilizers. Canadian Medical Association Journal 1958, January 15, 146.
85. Russell J. Methaqualones " heroin for lovers" Journal of the Mississippi State Medical Association 1973, 14(11):496-498.
86. Smith, A. (1960). Untitled essay. Rocky Mountain Medical Journal, March, 48, 49 [reprinted from a paper presented at the State Medical Journal Advertising Bureau, October 26, 1959 and located in Senate Anti-Trust and Monopoly, Drugs, Accession 71A 5170, Box 19, Record Group 46, National Archives Building, Washington, DC.].
87. Snelders S., Kaplan C., Pieters T. On cannabis, chloral hydrate, and career cycles of psychotropic drugs in medicine. Bulletin of the History of Medicine 2006, 80(1):95-114.
88. Spillane J. Debating the controlled substances act. Drug and Alcohol Dependence 2004, 76:17-29.
89. Staats E.B. Retail diversion of legal drugs: A major problem with no easy solution 1978, General Accounting Office, Washington, DC.
90. Swann J.P. FDA and the practice of pharmacy: Prescription drug regulation before the Durham-Humphrey amendment of 1951. Pharmacy in History 1994, 36:55-70.
91. Temin P. Taking your medicine: Drug regulation in the United States 1980, Harvard University Press, Cambridge.
92. Time. (1956). Don't-give-a-damn pills. February 27, 98.
93. Time (1957). Happiness by Prescription, March 11, 59.
94. Time (1960). Tranquil but Alert, March 7, 47.
95. Time. (1973). The Deadly Downer. March 5, 73.
96. Tobbell D. Allied against reform: Pharmaceutical industry-academic physician relations in the United States, 1945-1970. Bulletin of the History of Medicine 2008, 82(4):878-912.
97. Tomes N. The great American Medicine show revisited. Bulletin of the History of Medicine 2005, 79(4):627-663.
98. Tone A. Tranquilizers on trial: Psychopharmacology in the age of anxiety. Medicating modern America: Prescription drugs in history 2007, 156-181. New York University Press, New York. A. Tone, E.S. Watkins (Eds.).
99. Tone A. The age of anxiety: A history of America's turbulent affair with tranquilizers 2008, Basic Books, New York.
100. Altering American consciousness: Essays on the history of alcohol and drug use in the United States, 1800-2000 2004, University of Massachusetts Press, Boston. S. Tracy, C.J. Acker (Eds.).
101. Summary of Drug Control Actions under the Controlled Substances Act of 1970 1977, US Department of Justice, DEA Office of Compliance and Regulatory Affairs, Washington, DC.
102. US News and World Report. (1973). Latest drug danger: Another " relaxer." April 22, 60.
103. U.S. Senate. (1964). Committee on Government Operations, Subcommittee on Reorganization and International Organizations. Interagency Coordination in Drug Research and Regulation. Washington, D.C.: Government Printing Office.
104. U.S. Senate. (1973). Methaqualone (Quaalude, Sopor) Traffic, Abuse, and Regulation. Subcommittee to Investigate Juvenile Delinquency of the Committee on the Judiciary, US Senate, 93rd Cong., 1st Sess. Washington, D.C.: GPO, 1973.
105. U.S. Senate. (1982). Drug enforcement administration oversight and budget authorization and S. 2320. Subcommittee on Security and Terrorism of the Committee on the Judiciary, 97th Congress, 2nd. Sess., April 23. Washington: U.S. Government Printing Office.
106. US v. Witt. (1982). 82-CR. 33-CSH.
107. Vilkin M., Lomas J. Clinical experience with diazepam in general psychiatric practice. Journal of Neuropsychiatry 1962, (August [Suppl.]):139-144.
108. Watkins E. The estrogen elixir: A history of hormone replacement therapy in America 2007, Johns Hopkins University Press, Baltimore.
109. Weilburg, J. (1958). Risks and Rewards of Pharmaceutical Research. Smith Kline & French Laboratories [condensed by the company from The Bulletin of the Los Angeles County Medical Association, May 15, 1958, and located in Senate Anti-Trust and Monopoly, Drugs, Accession 71A 5170, Box 5, Record Group 46, National Archives Building, Washington, DC.].
110. Weissberg, K. (n.d.). Sopors are a bummer. Vibrations, 2(4).
111. Whiteside T. Getting there first with tranquility. The New Yorker 1958, May 3.
112. Whorton, J.C. (1980) " Antibiotic abandon": The resurgence of therapeutic rationalism. In Parascandola, J. (Ed.), The history of antibiotics (pp. 125-36). Madison: American Institute of the History of Pharmacy.
113. Rorer W.H. Quaalude advertisement. Medical World News 1965, December 31.
114. Woodward M. The facts behind the story: Pharmaceutical public relations. Bulletin of the Medical Library Association 1958, 46(1):55-57.
115. Young J.H. The toadstool millionaires: A social history of patent medicines in the United States before federal regulation 1961, Princeton University Press, Princeton.
116. Young J.H. Federal drug and narcotic legislation. Pharmacy in History 1995, 37:59-67.
117. Zito T. Sopors: Downs as a drug fad. Washington Post 1972, May 19, B1, B5.
118. Zwerdling D. Methaqualone: The " safe" drug that isn't very. Washington Post 1972, November 12.